Nigel Gupta
Kaiser Permanente
18 Papers
82 Citations
Nigel Gupta is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 6, co-authored 13 publications.
Chat about Author
Papers
Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study.
Alan S. Go,Alan S. Go,Alan S. Go,Kristi Reynolds,Jingrong Yang,Nigel Gupta,Judith C Lenane,Sue Hee Sung,Teresa N. Harrison,Taylor I. Liu,Matthew D. Solomon,Matthew D. Solomon +11 more
TL;DR: A greater burden of atrial fibrillation is associated with a higher risk of ischemic stroke independent of known stroke risk factors in adults with paroxysmal atrial Fibrillation.
Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes.
TL;DR: The Kaiser Permanente–Cardiac Device Registry is a robust tool to monitor postprocedural patient outcomes and postmarket surveillance of implants and potentially change practice patterns.
44
Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
Matthew J. Price,Chris Ellis,Jens Erik Nielsen-Kudsk,David Thaler,Nigel Gupta,Konstantinos Koulogiannis,Jordan A. Anderson,Ryan M. Gage,Dhanunjaya Lakkireddy +8 more
TL;DR: The Amulet IDE (AMPLATZER™ Amulet™ LAA Occluder Trial) randomized controlled trial as mentioned in this paper was designed to assess the incidence of and outcomes associated with left atrial appendage occlusion in patients with atrial fibrillation at increased stroke risk.
32
Longitudinal Study of Implantable Cardioverter-Defibrillators Methods and Clinical Characteristics of Patients Receiving Implantable Cardioverter-Defibrillators for Primary Prevention in Contemporary Practice
Frederick A. Masoudi,Alan S. Go,David J. Magid,Andrea E. Cassidy-Bushrow,Jonathan M. Doris,Frances Fiocchi,Romel Garcia-Montilla,Karen A. Glenn,Robert J. Goldberg,Nigel Gupta,Jerry H. Gurwitz,Stephen C. Hammill,John J. Hayes,Nathaniel Jackson,Alan H. Kadish,Michael R. Lauer,Aaron W. Miller,Deborah Multerer,Pamela N. Peterson,Liza M. Reifler,Kristi Reynolds,Jane S. Saczynski,Claudio Schuger,Param P. Sharma,David H. Smith,Mary Suits,Sue Hee Sung,Paul D. Varosy,Humberto Vidaillet,Robert T. Greenlee +29 more
TL;DR: Patients undergoing primary prevention ICD implantation in this study differ from those enrolled in the randomized, controlled trials that established the efficacy of ICDs, which will provide patients, clinicians, and policy makers with contemporary data to inform decision-making.
26
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network
Frederick A. Masoudi,Frederick A. Masoudi,Alan S. Go,Alan S. Go,David J. Magid,David J. Magid,Andrea E. Cassidy-Bushrow,Jerry H. Gurwitz,Taylor I. Liu,Kristi Reynolds,David H. Smith,Liza M. Reifler,Karen A. Glenn,Frances Fiocchi,Robert J. Goldberg,Nigel Gupta,Pamela N. Peterson,Pamela N. Peterson,Pamela N. Peterson,Claudio Schuger,Humberto Vidaillet,Stephen C. Hammill,Robert T. Greenlee +22 more
TL;DR: The burden of adverse outcomes after receipt of an implantable cardioverter-defibrillator for primary prevention is substantial and varies according to patient age and sex, but differences in outcome generally do not vary according to baseline heart failure characteristics.